Archive: February 2015

Long-term Toxicity of Chemotherapy and Radiotherapy in Lymphoma Survivors: Optimizing Treatment for Individual Patients

David C. Hodgson, MD, MPH, FRCPC

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   David C. Hodgson, MD, MPH, FRCPC Dr Hodgson is an associate professor in […]

Advances in the Diagnosis and Treatment of Childhood and Adolescent B-Cell Non-Hodgkin Lymphoma

Nader Kim El-Mallawany, MD, and Mitchell S. Cairo, MD

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Nader Kim El-Mallawany, MD, and Mitchell S. Cairo, MD The authors are affiliated […]

Bevacizumab vs EGFR Antibodies in Metastatic Colorectal Cancer

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Alan P. Venook, MD, Professor, Department of Medicine, Hematology/Oncology, University of California, San Francisco   H&O  […]

The Use of Granulocyte-Macrophage Colony-Stimulating Factor in Melanoma Treatment

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   F. Stephen Hodi, MD, Associate Professor, Harvard Medical School and Dana-Farber Cancer Institute, Boston, Massachusetts   […]

Kidney Cancer Update

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Starting with this issue, Clinical Advances in Hematology & Oncology is launching a […]

Redefining Dose-Limiting Toxicity

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Sophie Postel-Vinay, MD, PhD, Drug Development Department, Institut Gustave Roussy, Villejuif, France   H&O  How are […]

Evolving Treatments in Acute Myeloid Leukemia

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Gail J. Roboz, MD, Associate Professor of Medicine, Weill Medical College of Cornell University, New York […]

Highlights in Disorders of Coagulation and Thrombosis From the 2014 American Society of Hematology Meeting

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   December 6-9, 2014 • San Francisco, California Devon Schuyler and Kathryn Turner, PhD […]

Selecting Early Therapy in Prostate Cancer

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Daniel Petrylak, MD, Director, Genitourinary Oncology Research Program, Codirector, Signal Transduction Program, Yale Comprehensive Cancer Center, Yale […]

Letter From the Editor

Bruce D. Cheson, MD

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   I Am Charlie “The threat or fear of violence should not become an […]

Back to Archive